MHB039A

· Minghui Pharmaceutical (Hangzhou) Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MHB039A, covering 2025-11-18 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MHB039A for Advanced Solid Tumor [Phase 1, Phase 2]